{"id":"W4395690084","doi":"10.1007/s10549-024-07282-1","title":"Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care","year":2024,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society; Institute for Clinical Evaluative Sciences; Sunnybrook Research Institute","keywords":"Medicine; Breast cancer; Internal medicine; Trastuzumab; Oncology; Stage (stratigraphy); Triple-negative breast cancer; Population; Cancer; Cohort; Neoadjuvant therapy; Odds ratio; Logistic regression; Chemotherapy; Disease; Retrospective cohort study; Mastectomy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006335634,0.0001360423,0.0005704239,0.0002431844,0.0003589448,0.001406153,0.0002985784,0.000464578,0.0009148338],"category_scores_gemma":[0.008381365,0.0001055796,0.000217495,0.0004818277,0.0007455063,0.001294806,0.0004742809,0.001263457,0.0001446483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001217675,"about_ca_system_score_gemma":0.003362346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001456818,"about_ca_topic_score_gemma":0.006080792,"domain_scores_codex":[0.9979134,0.001285972,0.0001815211,0.00008417717,0.0004534553,0.00008145973],"domain_scores_gemma":[0.9962463,0.001646268,0.0008898535,0.0002541205,0.0004787986,0.0004846436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007518361,0.001257647,0.1077927,0.001771232,0.0003997303,0.0001939073,0.0003595467,0.000829061,0.01355147,0.01016107,0.01825809,0.8379073],"study_design_scores_gemma":[0.001607553,0.01789203,0.7158681,0.0053356,0.001175693,0.002635173,0.003200377,0.002099924,0.01455649,0.02278659,0.2126983,0.0001441021],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.4715539,0.3175768,0.007739278,0.1703184,0.003480314,0.0004721154,0.000394741,0.00006156494,0.02840292],"genre_scores_gemma":[0.8240947,0.1383062,0.01296234,0.01925092,0.002029084,0.0004079095,0.0004503042,0.00002782047,0.002470876],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.006335634,"threshold_uncertainty_score":0.03350639,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0263471542710184,"score_gpt":0.3678095736712091,"score_spread":0.3414624194001907,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}